Your browser doesn't support javascript.
loading
ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents.
Shah, Amy S; Zeitler, Philip S; Wong, Jencia; Pena, Alexia S; Wicklow, Brandy; Arslanian, Silva; Chang, Nancy; Fu, Junfen; Dabadghao, Preeti; Pinhas-Hamiel, Orit; Urakami, Tatsuhiko; Craig, Maria E.
Affiliation
  • Shah AS; Division of Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, Ohio, USA.
  • Zeitler PS; Division of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Wong J; Department of Endocrinology, Royal Prince Alfred Hospital and Central Clinical School, Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Pena AS; The University of Adelaide, Robinson Research Institute, North Adelaide, South Australia, Australia.
  • Wicklow B; Division of Endocrinology, Winnipeg Children's Hospital and University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada.
  • Arslanian S; Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Chang N; Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Fu J; Division of Endocrinology, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Dabadghao P; Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Pinhas-Hamiel O; Edmond and Lily Safra Children's Hospital, Sackler School of Medicine, Tel-Aviv, Israel.
  • Urakami T; Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
  • Craig ME; The Children's Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia.
Pediatr Diabetes ; 23(7): 872-902, 2022 11.
Article de En | MEDLINE | ID: mdl-36161685

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / COVID-19 Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limites: Adolescent / Adult / Child / Humans Langue: En Journal: Pediatr Diabetes Sujet du journal: ENDOCRINOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / COVID-19 Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limites: Adolescent / Adult / Child / Humans Langue: En Journal: Pediatr Diabetes Sujet du journal: ENDOCRINOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique